Jennison Associates LLC Alkermes Plc. Transaction History
Jennison Associates LLC
- $170 Billion
- Q3 2025
A detailed history of Jennison Associates LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Jennison Associates LLC holds 19,570 shares of ALKS stock, worth $568,312. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,570
Previous 31,761
38.38%
Holding current value
$568,312
Previous $908,000
35.35%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ALKS
# of Institutions
401Shares Held
176MCall Options Held
901KPut Options Held
400K-
Black Rock Inc. New York, NY29.1MShares$845 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$528 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.2MShares$297 Million0.03% of portfolio
-
State Street Corp Boston, MA8.54MShares$248 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY8.09MShares$235 Million1.98% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.77B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...